Investors

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Calendar

February 26, 2025 - Year-end Report Q4 2024 (7:00am CET)
March 12, 2025 - Carnegie Nordic Healthcare Conference (Stockholm)
April 2, 2025 - Van Lanschot Kempen Life Sciences Conference (Amsterdam)
April 30, 2025 - Interim Report Q1 2025 (7:00am CEST)
May 6, 2025 - Annual General Meeting

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: [email protected]